Bart Claassen

Canisius-Wilhelmina Ziekenhuis

Papers

1

Total Citations

14

H-Index

1

About

Bart Claassen is at the forefront of integrating artificial intelligence with oncologic imaging, with a primary focus on improving prostate cancer diagnostics. His key research areas include AI-driven radiology, predictive modeling, and the enhancement of MRI-based cancer staging. Claassen’s major contribution lies in developing and externally validating sophisticated machine learning models that leverage 3 Tesla multiparametric MRI to more accurately predict lesion-specific extraprostatic extension (EPE) in prostate cancer patients. This work directly addresses a critical clinical challenge, as conventional radiomics often falls short in detecting EPE, which is vital for treatment planning and prognosis. His most cited paper, published in 2023, has already garnered 14 citations, signaling its rapid impact and relevance in the field. By demonstrating that AI-driven models can outperform traditional methods, Claassen is paving the way for more precise, non-invasive cancer staging. His achievements highlight a promising shift toward personalized medicine, where computational tools enhance diagnostic accuracy and ultimately improve patient outcomes. For students and researchers, Claassen’s work exemplifies the transformative potential of AI in clinical radiology.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
The Development and External Validation of Artificial Intelligence-Driven MRI-Based Models to Improve Prediction of Lesion-Specific Extraprostatic Extension in Patients with Prostate Cancer
14 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Canisius-Wilhelmina Ziekenhuis

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago